Acadia Pharmaceuticals buy Morgan Stanley
Start price
18.03.24
/
50%
€17.30
Target price
18.03.25
€27.59
Performance (%)
-9.74%
Price
26.04.24
€15.62
Summary
This prediction is currently active. With a performance of -9.74%, the BUY prediction for Acadia Pharmaceuticals by Morgan_Stanley is down slightly. This prediction currently runs until 18.03.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -2.131% | -2.131% |
iShares Core DAX® | 0.961% | -2.210% |
iShares Nasdaq 100 | 2.626% | -1.918% |
iShares Nikkei 225® | 0.217% | -7.216% |
iShares S&P 500 | 1.540% | -1.858% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Morgan Stanley from $40.00 to $30.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
19.12.23
19.12.23
€36.48
19.12.24
19.12.24
-43.01%
26.04.24
26.04.24